“…Cutaneous leishmaniasis (CL) is still considered an important health problem in many parts of the world, especially the Mediterranean region, some countries of Africa, and almost all countries of the Middle East, including Iran (Momeni, 1994;Ozbel et al, 1995;Khoury et al, 1996;Alimohammadian et al, 1999). The prevalence of infection is high in some provinces of Iran, including Isfahan (Nadim and Faghih, 1968;Salimi, 2000), Shiraz (Moaddeb et al, 1993), Khorasan (Javadian et al, 1967), and Khozestan and Kerman (Nadim and Seyedi, 1971).…”